• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

影响初级保健提供者药物减量的因素差异:横断面研究。

Differences in Factors Influencing Deprescribing between Primary Care Providers: Cross-Sectional Study.

机构信息

Faculty of Pharmacy and Biochemistry, University of Zagreb, A. Kovačića 1, 10 000 Zagreb, Croatia.

City Pharmacies Zagreb, Kralja Držislava 6, 10 000 Zagreb, Croatia.

出版信息

Int J Environ Res Public Health. 2023 Mar 11;20(6):4957. doi: 10.3390/ijerph20064957.

DOI:10.3390/ijerph20064957
PMID:36981865
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10049550/
Abstract

Deprescribing is a notable approach to improve medication management, but few healthcare systems recognize it. To introduce a new practice, it is important to examine the factors influencing the provision of a new or elaborate cognitive service within the desired setting. This study explores the perceived barriers and facilitators of deprescribing by primary healthcare providers, and identifies the factors associated with a willingness to suggest deprescribing. A cross-sectional survey was conducted (in Croatia, between October 2021 and January 2022) using a validated comprehensive healthcare providers' opinions, preferences, and attitudes towards deprescribing (CHOPPED) questionnaire. A total of 419 pharmacists and 124 physicians participated. Participants showed a high willingness to deprescribe, with significantly higher scores in physicians than in pharmacists (5.00 (interquartile range-IQR 5-5) vs. 4.00 (IQR 4-5), < 0.001). Pharmacists had significantly higher scores in seven out of ten factors (knowledge, awareness, collaboration facilitators, competencies facilitators, healthcare system facilitators, collaboration barriers, competencies barriers) while in the remaining three factors (patient facilitators, patient and healthcare system barriers) there was no difference in scores. The strongest positive correlation with willingness to suggest deprescribing was found with the collaboration and healthcare system facilitators factors for pharmacists (G = 0.331, < 0.001, and G = 0.309, < 0.001, respectively), and with knowledge, awareness, and patient facilitators factors for physicians (G = 0.446, = 0.001; G = 0.771, < 0.001; and G = 0.259, = 0.043, respectively). Primary healthcare providers are willing to suggest deprescribing but face different barriers and facilitators. For pharmacists, the most important facilitators were extrinsic, while for physicians they were more intrinsic and patient related. The stated results provide target areas which one could focus upon to help to engage healthcare providers in deprescribing.

摘要

减药是改善药物管理的一种重要方法,但很少有医疗保健系统认识到这一点。要引入一种新的实践,重要的是要研究在既定环境中提供新的或精细的认知服务的影响因素。本研究探讨了初级保健提供者对减药的认知障碍和促进因素,并确定了与愿意建议减药相关的因素。这项横断面调查(在克罗地亚,2021 年 10 月至 2022 年 1 月期间进行)使用了经过验证的全面医疗保健提供者对减药的意见、偏好和态度(CHOPPED)问卷。共有 419 名药剂师和 124 名医生参与了这项研究。参与者表示愿意减药,医生的得分明显高于药剂师(5.00(四分位距 IQR 5-5)比 4.00(IQR 4-5),<0.001)。药剂师在十个因素中的七个因素上的得分明显较高(知识、意识、协作促进因素、能力促进因素、医疗保健系统促进因素、协作障碍、能力障碍),而在另外三个因素(患者促进因素、患者和医疗保健系统障碍)上,得分没有差异。与建议减药意愿呈最强正相关的是药剂师的协作和医疗保健系统促进因素(G = 0.331,<0.001,和 G = 0.309,<0.001),以及医生的知识、意识和患者促进因素(G = 0.446,= 0.001;G = 0.771,<0.001;和 G = 0.259,= 0.043)。初级保健提供者愿意建议减药,但面临着不同的障碍和促进因素。对于药剂师来说,最重要的促进因素是外在的,而对于医生来说,促进因素则更多地与内在因素和患者相关。这些结果为我们提供了目标领域,可以关注这些领域来帮助医疗保健提供者参与减药。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6594/10049550/8f63403e8896/ijerph-20-04957-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6594/10049550/248b6802cb5e/ijerph-20-04957-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6594/10049550/8f63403e8896/ijerph-20-04957-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6594/10049550/248b6802cb5e/ijerph-20-04957-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6594/10049550/8f63403e8896/ijerph-20-04957-g002.jpg

相似文献

1
Differences in Factors Influencing Deprescribing between Primary Care Providers: Cross-Sectional Study.影响初级保健提供者药物减量的因素差异:横断面研究。
Int J Environ Res Public Health. 2023 Mar 11;20(6):4957. doi: 10.3390/ijerph20064957.
2
Development and Validation of Comprehensive Healthcare Providers' Opinions, Preferences, and Attitudes towards Deprescribing (CHOPPED Questionnaire).综合医疗服务提供者对减药的意见、偏好和态度的问卷(CHOPPED问卷)的开发与验证
Pharmacy (Basel). 2022 Jul 1;10(4):76. doi: 10.3390/pharmacy10040076.
3
Pharmacists' attitudes towards interprofessional collaboration to optimise medication use in older patients in Switzerland: a survey study.瑞士药剂师对优化老年患者用药的跨专业合作态度:一项调查研究。
BMC Health Serv Res. 2024 Jul 26;24(1):849. doi: 10.1186/s12913-024-11339-8.
4
Deprescribing practice in a resource-limited setting: Healthcare providers' insights.在资源有限的情况下减少用药实践:医疗保健提供者的见解。
Int J Clin Pract. 2021 Sep;75(9):e14356. doi: 10.1111/ijcp.14356. Epub 2021 May 24.
5
eConsultation for Deprescribing Among Older Adults: Clinician Perspectives on Implementation Barriers and Facilitators.老年人减药的电子咨询:临床医生对实施障碍和促进因素的看法
J Gen Intern Med. 2024 Oct;39(13):2461-2470. doi: 10.1007/s11606-024-08899-0. Epub 2024 Jun 28.
6
Challenges and opportunities in creating a deprescribing program in the emergency department: A qualitative study.在急诊科创建药物减量计划面临的挑战和机遇:一项定性研究。
J Am Geriatr Soc. 2023 Jan;71(1):62-76. doi: 10.1111/jgs.18047. Epub 2022 Oct 18.
7
Barriers and Enablers of Healthcare Providers to Deprescribe Cardiometabolic Medication in Older Patients: A Focus Group Study.医疗保健提供者在老年患者中停止使用心血管代谢药物的障碍和促进因素:一项焦点小组研究。
Drugs Aging. 2022 Mar;39(3):209-221. doi: 10.1007/s40266-021-00918-7. Epub 2022 Feb 21.
8
Assessing community pharmacists' attitudes towards identifying opportunities for deprescribing in clinical practice in Ireland.评估爱尔兰社区药剂师在临床实践中识别药物减量机会的态度。
Int J Pharm Pract. 2022 Jan 7;30(1):28-35. doi: 10.1093/ijpp/riab079.
9
Barriers, facilitators and needs to deprescribe benzodiazepines and other sedatives in older adults: a mixed methods study of primary care provider perspectives.在老年人中减少苯二氮䓬类药物和其他镇静剂的使用:初级保健提供者观点的混合方法研究中的障碍、促进因素和需求。
BMC Geriatr. 2024 May 4;24(1):396. doi: 10.1186/s12877-024-05027-9.
10
Deprescribing in a multimorbid older adult: A case vignette study among community pharmacists and primary care physicians.多疾病老年患者减药:社区药剂师和初级保健医生案例描述研究。
Basic Clin Pharmacol Toxicol. 2023 Dec;133(6):729-740. doi: 10.1111/bcpt.13899. Epub 2023 May 22.

引用本文的文献

1
Pharmacists' attitudes towards interprofessional collaboration to optimise medication use in older patients in Switzerland: a survey study.瑞士药剂师对优化老年患者用药的跨专业合作态度:一项调查研究。
BMC Health Serv Res. 2024 Jul 26;24(1):849. doi: 10.1186/s12913-024-11339-8.

本文引用的文献

1
Deprescribing practices, habits and attitudes of geriatricians and geriatricians-in-training across Europe: a large web-based survey.在欧洲,老年医学专家和老年医学实习生的减药实践、习惯和态度:一项大型的网络调查。
Eur Geriatr Med. 2022 Dec;13(6):1455-1466. doi: 10.1007/s41999-022-00702-9. Epub 2022 Nov 2.
2
Establishing the worth of deprescribing inappropriate medications: are we there yet?确定停用不适当药物的价值:我们做到了吗?
Med J Aust. 2022 Sep 19;217(6):283-286. doi: 10.5694/mja2.51686. Epub 2022 Aug 28.
3
Development and Validation of Comprehensive Healthcare Providers' Opinions, Preferences, and Attitudes towards Deprescribing (CHOPPED Questionnaire).
综合医疗服务提供者对减药的意见、偏好和态度的问卷(CHOPPED问卷)的开发与验证
Pharmacy (Basel). 2022 Jul 1;10(4):76. doi: 10.3390/pharmacy10040076.
4
Multidisciplinary Approach to Deprescribing Sedative-Hypnotic Medications in Geriatric Primary Care.老年初级保健中镇静催眠药物逐渐停用的多学科方法。
J Prim Care Community Health. 2022 Jan-Dec;13:21501319221103416. doi: 10.1177/21501319221103416.
5
Health system reforms and the needs of the ageing population-an analysis of recent policy paths and reform trends in Finland and Sweden.卫生系统改革与老龄化人口的需求——芬兰和瑞典近期政策路径与改革趋势分析
Eur J Ageing. 2022 Apr 15;19(2):221-232. doi: 10.1007/s10433-022-00699-x. eCollection 2022 Jun.
6
Development and validation of a tool to understand health care professionals' attitudes towards deprescribing (HATD) in older adults with limited life expectancy.开发和验证一种工具,以了解医疗保健专业人员对有限预期寿命的老年患者进行药物减量治疗的态度(HATD)。
Res Social Adm Pharm. 2022 Sep;18(9):3596-3601. doi: 10.1016/j.sapharm.2022.03.002. Epub 2022 Mar 8.
7
Multidisciplinary Team Deprescribing Intervention for Polypharmacy in Elderly Orthopedic Inpatients: A Propensity Score-matched Analysis of a Retrospective Cohort Study.多学科团队对老年骨科住院患者多重用药的减药干预:一项回顾性队列研究的倾向评分匹配分析
Intern Med. 2022 Aug 15;61(16):2417-2426. doi: 10.2169/internalmedicine.8929-21. Epub 2022 Jan 13.
8
Assessing community pharmacists' attitudes towards identifying opportunities for deprescribing in clinical practice in Ireland.评估爱尔兰社区药剂师在临床实践中识别药物减量机会的态度。
Int J Pharm Pract. 2022 Jan 7;30(1):28-35. doi: 10.1093/ijpp/riab079.
9
Deprescribing: a call for research that supports implementation in practice.减药:呼吁开展支持在实践中实施的研究。
Int J Pharm Pract. 2021 Dec 4;29(6):525-526. doi: 10.1093/ijpp/riab074.
10
Healthcare professionals' knowledge, attitudes and practices toward deprescribing: a protocol of cross-sectional study (Desmedica Study-Brazil).医疗保健专业人员对药物减量的知识、态度和实践:一项横断面研究方案(Desmedica 研究-巴西)。
BMJ Open. 2021 Aug 2;11(8):e044312. doi: 10.1136/bmjopen-2020-044312.